Your browser doesn't support javascript.
loading
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial.
Porras, Carolina; Sampson, Joshua N; Herrero, Rolando; Gail, Mitchell H; Cortés, Bernal; Hildesheim, Allan; Cyr, Jean; Romero, Byron; Schiller, John T; Montero, Christian; Pinto, Ligia A; Schussler, John; Coronado, Karla; Sierra, Mónica S; Kim, Jane J; Torres, Catherine M; Carvajal, Loretto; Wagner, Sarah; Campos, Nicole G; Ocampo, Rebecca; Kemp, Troy J; Zuniga, Michael; Lowy, Douglas R; Avila, Carlos; Chanock, Stephen; Castrillo, Ariane; Estrada, Yenory; Barrientos, Gloriana; Monge, Cindy; Oconitrillo, María Y; Kreimer, Aimée R.
Afiliação
  • Porras C; Agencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San José, Costa Rica. Electronic address: cporras@acibcr.com.
  • Sampson JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Herrero R; Agencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San José, Costa Rica.
  • Gail MH; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Cortés B; Agencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San José, Costa Rica.
  • Hildesheim A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Cyr J; Information Management Services, Silver Spring, MD, USA.
  • Romero B; Agencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San José, Costa Rica.
  • Schiller JT; Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Montero C; Agencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San José, Costa Rica.
  • Pinto LA; HPV Serology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Schussler J; Information Management Services, Silver Spring, MD, USA.
  • Coronado K; Agencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San José, Costa Rica.
  • Sierra MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Kim JJ; Center for Health Decision Science, Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Torres CM; Westat, Rockville, MD, USA.
  • Carvajal L; Agencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San José, Costa Rica.
  • Wagner S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, USA.
  • Campos NG; Center for Health Decision Science, Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Ocampo R; Agencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San José, Costa Rica.
  • Kemp TJ; HPV Serology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Zuniga M; Agencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San José, Costa Rica.
  • Lowy DR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Avila C; Agencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San José, Costa Rica.
  • Chanock S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Castrillo A; Agencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San José, Costa Rica.
  • Estrada Y; Agencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San José, Costa Rica.
  • Barrientos G; Agencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San José, Costa Rica.
  • Monge C; Agencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San José, Costa Rica.
  • Oconitrillo MY; Agencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San José, Costa Rica.
  • Kreimer AR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: kreimera@mail.nih.gov.
Vaccine ; 40(1): 76-88, 2022 01 03.
Article em En | MEDLINE | ID: mdl-34857420
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 10_ODS3_salud_sexual_reprodutiva / 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus / Alphapapillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Clinical_trials Limite: Adolescent / Child / Female / Humans País/Região como assunto: America central / Costa rica Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 10_ODS3_salud_sexual_reprodutiva / 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus / Alphapapillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Clinical_trials Limite: Adolescent / Child / Female / Humans País/Região como assunto: America central / Costa rica Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article